Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Folic Acid and Trimethoprim, Sulfamethoxazole Drug Combination

Research Papers that Mention the Interaction

“ Cotrimoxazole (CTX) inhibits folic acid synthesis which is important for the survival of many bacteria, protozoa, and fungi and has been used to prevent several opportunistic infections among HIV/AIDS patients.”
Emerging microbes & infections  •  2019  |  View Paper
“For example, cotrimoxazole (trimethoprim-sulfamethoxazole) inhibits folic acid metabolism through direct binding to dihydrofolate reductase, an enzyme which is also inhibited by methotrexate.”
Drug safety  •  1995  |  View Paper
“Accordingly, folic acid can reverse the action of TMP-SMX.”
“It should be remembered that many of the best-selling vitamin supplements in the United States (compared with many of the European products) contain substantial amounts of folic acid that will probably interfere with the action of TMP-SMX.”
“Patients receiving TMP-SMX should be questioned about their use of vitamins and should be advised not to use supplements containing folic acid.”
Annals of Internal Medicine  •  1995  |  View Paper
“ Trimethoprim-sulfamethoxazole is a well-known antibiotic that inhibits folic acid synthesis, a topic of renewed interest.”
Antibiotics  •  2021  |  View Paper
“ Folic acid co-administration with co-trimoxazole partially reversed the decrease in sperm quality and structural abnormalities of high doses of co-trimoxazole (60 and 120 mg/kg/daily) (p<0.001).”
International journal of reproductive biomedicine  •  2017  |  View Paper
“ Folic acid co-administration with co-trimoxazole reversed partially all these parameters compared to the co-trimoxazole group (P<0.001).”
Iranian journal of medical sciences  •  2017  |  View Paper